Genenta Science

This company operates as a strategic industrial consolidator focused on defense, aerospace, and national security sectors. It develops cell therapies, such as the Temferon platform, while also managing high-precision manufacturing subsidiaries like Sòphia High Tech. The firm targets critical industries and government-shielded sectors to build industrial champions within the European market.